Longeveron Company

Longeveron is a biotechnology company developing regenerative medicines for the treatment of life threatening diseases associated with ageing.
Technology: Regenerative Medicine
Industry: Cell Therapy
Headquarters: Miami, Florida, United States
Founded Date: 2014
Employees Number: 11-50
Funding Status: IPO
Investors Number: 3
Total Funding: $9M
Estimated Revenue: $1M to $10M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership